Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations

European Radiology

Volumn 13, Issue 2, 2003, Pages 294-298

  Dosdá, Rosa ^a   Martí Bonmatí, Luis ^a   Ronchera Oms, Crisanto L ^b   Mollá, Enrique ^a   Arana, Estanislao ^a  

^a HOSPITAL QUIRÓN   (Spain)

^b Fundacion Univ San Pablo CEU   (Spain)

Author keywords

Butylscopolamine; Gastrointestinal tract; MR artifacts; MR noise reduction; MR studies

Indexed keywords

BUSCAPINA; GADODIAMIDE; GADOLINIUM PENTETATE; SCOPOLAMINE BUTYL BROMIDE;

ABDOMINAL CRAMP; AGE; ARTICLE; ARTIFACT REDUCTION; BODY WEIGHT; BREATH HOLDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; GENDER; HEADACHE; HEART PALPITATION; HUMAN; IMAGE QUALITY; INTESTINE MOTILITY; MYDRIASIS; NAUSEA; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TACHYCARDIA; URTICARIA; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0037742326     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1500-5     Document Type: Article

References (17)

1. Bellon EM, Haacke EM, Coleman PE, Sacco DC, Steiger DA, Gangarosa RE (1986) MR artifacts: a review. Am J Roentgenol 147:1271-1281
2. Wood ML, Runge VM, Henkelman RM (1988) Overcoming motion in abdominal MR imaging. Am J Roent-genol 150:513-522
3. Stark DD, Hendrick RE, Hahn PF, Ferrucci JT (1987) Motion artifact reduction with fast spin-echo imaging. Radiology 164:183-191
4. Van de Walle R, Lemahieu I, Achten E (1997) Magnetic resonance imaging and the reduction of motion artifacts: review of the principles. Technol Health Care 5:419-435
5. Laniado M, Grönewallër E, Kopp AF, Kaminsky SF, Hamm B, Jacobsen TF, Claussen CD (1997) The value of hyoscine butylbromide in abdominal MR imaging with and without magnetic particles. Abdom Imaging 22:381-388
6. Martí-Bonmatí L, Graells M, Ronchera-Oms CL (1996) Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: comparative evaluation of three drugs. Abdom Imaging 21:309-313
7. Weinreb JC, Maravilla KR, Redman HC, Nunnaly R (1984) Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr 8:835-838
8. Brown JJ, Duncan JR, Heiken JP et al. (1991) Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 181:455-460
9. Kaminsky S, Laniado M, Gogoll M et al. (1991) Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178:503-508
10. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA (1989) Measuring signal-to-noise ratios in MR imaging. Radiology 173:265-267
11. Martí-Bonmatí L, Dosdá R, Ronchera-Oms CL, Casillas C (1999) Dose effects of dicyclomine on the reduction of peristaltic artifacts on MR imaging of the abdomen. Abdom Imaging 24:336-339
12. Moeller G, Hughes JJ, Mangano FA, Gelormini R, Tomlinson TL, DiPalma JA (1992) Comparison of L-hyoscyamine, glucagon, and placebo for air-contrast upper gastrointestinal series. Gastrointest Radiol 17:195-198
13. Bova JG, Jurdi RA, Bennett WF (1993) Antispasmodic drugs to reduce discomfort and colonic spasm during barium enemas: comparison of oral hyoscyamine, IV glucagon, and no drug. Am J Roentgenol 161:965-968
14. Braccini G, Marraccini P, Marrucci A, Boraschi P, Falaschi F, Testa R, Bartolozzi C (1994) Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide. Abdom Imaging 19:201-206
15. Skucas J (1994) The use of antispasmodic drugs during barium enemas. Am J Roentgenol 162:1323-1325
16. Kozak RI, Bennett JD, Brown TC, Lee TY (1994) Reduction of bowel motion artifact during digital subtraction angiography: a comparison of hyoscine butylbromide and glucagon. Can Assoc Radiol J 45:209-211
17. Maher R, Phillips-Hughes J, Banning A, Boardman P (1999) The frequency and significance of silent myocardial ischemia due to hyoscine butylbromide use in peripheral angiography. Cardiovasc Intervent Radiol 22:369-374